One week eradication regimen for Helicobacter pylori.

作者: R.P.H. Logan , P.A. Gummett , J.J. Misiewicz , Q.N. Karim , M.M. Walker

DOI: 10.1016/0140-6736(91)92111-E

关键词:

摘要: Abstract Although Helicobacter pylori is both a frequent cause of gastritis and an important factor in duodenal ulcer recurrence, no treatment regimen exists that completely safe effective. We have studied short eradication tripotassium dicitrato bismuthate 120 mg four times daily amoxycillin 500 for seven days with metronidazole 400 five three (days 5-7). 106 patients peptic ulceration non-ulcer dyspepsia, who were also infected H pylori, entered into the study. was successfully eradicated 76/106 (72%) (median follow-up 9·3 months). The rate higher among metronidazole-sensitive (40/43, 93%). In 17/30 whom failed, pretreatment metronidazole-resistant strains subsequently isolated. Side-effects mild, commonest (24/106, 24%) being taste disturbance metronidazole. A one-week safe, effective, cheap, well-tolerated pylori.

参考文章(15)
Erik A.J. Rauws, Wies Langenberg, Guido N.J. Tytgat, Hendrik J. Houthoff, H.C. Zanen, Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology. ,vol. 94, pp. 33- 40 ,(1988) , 10.5555/URI:PII:0016508588906063
Widdicombe Jg, Reflex control of airways smooth muscle. Postgraduate Medical Journal. ,vol. 51, pp. 36- 44 ,(1975)
C Neumann, Ivd Weller, Dj Jeffries, Pjv Hanson, Bg Gazzard, Cb Williams, Ig Barrison, Atr Axon, G Ayliffe, CLEANING AND DISINFECTION OF EQUIPMENT FOR GASTROINTESTINAL FLEXIBLE ENDOSCOPY - INTERIM RECOMMENDATIONS OF A WORKING PARTY OF THE BRITISH-SOCIETY-OF-GASTROENTEROLOGY - REPLY Gut. ,(1988)
R.P.H Logan, R.J Polson, J.H Baron, J.J Misiewicz, Follow-up after anti-Helicobacter pylori treatment The Lancet. ,vol. 337, pp. 562- 563 ,(1991) , 10.1016/0140-6736(91)91358-2
J. WEIL, G. D. BELL, K. POWELL, A. MORDEN, G. HARRISON, P. W. GANT, P. H. JONES, J. E. TROWELL, Helicobacter pylori infection treated with a tripotassium dicitrato bismuthate and metronidazole combination. Alimentary Pharmacology & Therapeutics. ,vol. 4, pp. 651- 657 ,(2007) , 10.1111/J.1365-2036.1990.TB00513.X
J Weil, G.D Bell, K Powell, R Jobson, J.E Trowell, P Gant, P.H Jones, Helicobacter pylori and metronidazole resistance The Lancet. ,vol. 336, pp. 1445- 1445 ,(1990) , 10.1016/0140-6736(90)93145-F
D. Forman, F. Sitas, D. G. Newell, A. R. Stacey, J. Boreham, R. Peto, T. C. Campbell, J. Li, J. Chen, Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. International Journal of Cancer. ,vol. 46, pp. 608- 611 ,(1990) , 10.1002/IJC.2910460410
E.A.J. Rauws, G.N.J. Tytgat, Cure of duodenal ulcer associated with eradication of Helicobacter pylori The Lancet. ,vol. 335, pp. 1233- 1235 ,(1990) , 10.1016/0140-6736(90)91301-P
D Forman, D G Newell, F Fullerton, J W Yarnell, A R Stacey, N Wald, F Sitas, Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ. ,vol. 302, pp. 1302- 1305 ,(1991) , 10.1136/BMJ.302.6788.1302
Peter J Jenks, David I Edwards, Metronidazole resistance in Helicobacter pylori. The Lancet. ,vol. 335, pp. 976- 977 ,(1990) , 10.1016/0140-6736(90)91043-A